| Dr Michael A Gordon, MD | |
|
990 Stewart Ave, Suite 610, Garden City, NY 11530-4838 | |
| (516) 222-1881 | |
| (516) 222-1885 |
| Full Name | Dr Michael A Gordon |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 38 Years |
| Location | 990 Stewart Ave, Garden City, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356306807 | NPI | - | NPPES |
| 01432640 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 171522 (New York) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ent And Allergy Associates Llp | 0749193662 | 368 |
News Archive
A selection of health policy stories from California. A bill that would have allowed "biosimilar" drugs to be substituted for biologic drugs was vetoed over the weekend by Gov. Jerry Brown (D), who said it was premature to pass the law until the Federal Drug Administration has worked out standards for the new drugs.
Arthritis & Osteoporosis NSW has recently launched the Juvenile Arthritis Campaign aimed at raising much needed awareness and funds for the thousands of children struggling with arthritis throughout NSW. More than 6,000 children live with the condition and there are many more yet to be diagnosed.
Research has shown that being single, married or divorced can influence cancer survival, but a new study shows marital status appears to have no impact on the outcome for women with breast cancer who are treated with lumpectomy and radiation.
Today from Medpi 2010, Smartfish Technologies announced its second strategic partnership to distribute and sell its ErgoMotion™ technology with Mobility Lab of France. As part of its agreement with Mobility Lab, Smartfish will provide its award-winning ErgoMotion technology to Mobility Lab for distribution to retailers in France, Switzerland, Netherlands, Belgium, Luxemburg and Spain. Smartfish will manufacture the resulting Mobility Lab branded products powered by ErgoMotion.
A drug recently approved by the Food & Drug Administration for the treatment of prostate cancer is proving to give some patients the gift of time. A new study shows abiraterone acetate extends the lives of men with the most advanced form of the disease by about four months.
› Verified 4 days ago
| Entity Name | Ent And Allergy Associates Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376598326 PECOS PAC ID: 0749193662 Enrollment ID: O20031107000043 |
News Archive
A selection of health policy stories from California. A bill that would have allowed "biosimilar" drugs to be substituted for biologic drugs was vetoed over the weekend by Gov. Jerry Brown (D), who said it was premature to pass the law until the Federal Drug Administration has worked out standards for the new drugs.
Arthritis & Osteoporosis NSW has recently launched the Juvenile Arthritis Campaign aimed at raising much needed awareness and funds for the thousands of children struggling with arthritis throughout NSW. More than 6,000 children live with the condition and there are many more yet to be diagnosed.
Research has shown that being single, married or divorced can influence cancer survival, but a new study shows marital status appears to have no impact on the outcome for women with breast cancer who are treated with lumpectomy and radiation.
Today from Medpi 2010, Smartfish Technologies announced its second strategic partnership to distribute and sell its ErgoMotion™ technology with Mobility Lab of France. As part of its agreement with Mobility Lab, Smartfish will provide its award-winning ErgoMotion technology to Mobility Lab for distribution to retailers in France, Switzerland, Netherlands, Belgium, Luxemburg and Spain. Smartfish will manufacture the resulting Mobility Lab branded products powered by ErgoMotion.
A drug recently approved by the Food & Drug Administration for the treatment of prostate cancer is proving to give some patients the gift of time. A new study shows abiraterone acetate extends the lives of men with the most advanced form of the disease by about four months.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael A Gordon, MD 660 White Plains Rd Fl 4, Tarrytown, NY 10591-5139 Ph: (914) 984-2546 | Dr Michael A Gordon, MD 990 Stewart Ave, Suite 610, Garden City, NY 11530-4838 Ph: (516) 222-1881 |
News Archive
A selection of health policy stories from California. A bill that would have allowed "biosimilar" drugs to be substituted for biologic drugs was vetoed over the weekend by Gov. Jerry Brown (D), who said it was premature to pass the law until the Federal Drug Administration has worked out standards for the new drugs.
Arthritis & Osteoporosis NSW has recently launched the Juvenile Arthritis Campaign aimed at raising much needed awareness and funds for the thousands of children struggling with arthritis throughout NSW. More than 6,000 children live with the condition and there are many more yet to be diagnosed.
Research has shown that being single, married or divorced can influence cancer survival, but a new study shows marital status appears to have no impact on the outcome for women with breast cancer who are treated with lumpectomy and radiation.
Today from Medpi 2010, Smartfish Technologies announced its second strategic partnership to distribute and sell its ErgoMotion™ technology with Mobility Lab of France. As part of its agreement with Mobility Lab, Smartfish will provide its award-winning ErgoMotion technology to Mobility Lab for distribution to retailers in France, Switzerland, Netherlands, Belgium, Luxemburg and Spain. Smartfish will manufacture the resulting Mobility Lab branded products powered by ErgoMotion.
A drug recently approved by the Food & Drug Administration for the treatment of prostate cancer is proving to give some patients the gift of time. A new study shows abiraterone acetate extends the lives of men with the most advanced form of the disease by about four months.
› Verified 4 days ago
Saul Michael Modlin, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 300 Garden City Plaza, Suite 248, Garden City, NY 11530 Phone: 516-739-0333 Fax: 516-739-0344 | |
Dr. Jeffrey Zauderer, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 990 Stewart Ave, Suite 610, Garden City, NY 11530 Phone: 516-280-1701 Fax: 516-222-1885 | |
Jay S Rechtweg, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 990 Stewart Ave, Suite 610, Garden City, NY 11530 Phone: 516-222-1881 Fax: 516-222-1885 | |
Dr. Michael Guy Mendelsohn, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 990 Stewart Ave, Suite 610, Garden City, NY 11530 Phone: 516-222-1881 Fax: 516-222-1885 | |
Dr. Paul A Bell, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 990 Stewart Avenue, Suite 610, Garden City, NY 11530 Phone: 516-739-3999 Fax: 516-739-1097 | |
Dr. Rajesh S Kakani, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 877 Stewart Ave, Suite 2, Garden City, NY 11530 Phone: 516-222-1105 Fax: 516-222-1161 |